Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 26;16(2):e0246862.
doi: 10.1371/journal.pone.0246862. eCollection 2021.

Elucidating the impact of obesity on hormonal and metabolic perturbations in polycystic ovary syndrome phenotypes in Indian women

Affiliations

Elucidating the impact of obesity on hormonal and metabolic perturbations in polycystic ovary syndrome phenotypes in Indian women

Roshan Dadachanji et al. PLoS One. .

Abstract

Polycystic ovary syndrome is a complex endocrinopathy with heterogeneous presentation and multifactorial etiology. We have undertaken this case-control study to compare metabolic and endocrine characteristics in different phenotypic subgroups of women with PCOS and the impact of obesity on them. Women with PCOS (n = 489) were classified into 4 phenotypes according to Rotterdam criteria. Comparisons of clinical, biochemical and hormonal parameters were performed across all phenotypic groups of PCOS and with controls (n = 270) by Welch's ANOVA with subsequent Games-Howell post-hoc test. We found maximum prevalence of normoandrogenic phenotype D, which is milder form of PCOS in terms of insulin resistance, gonadotropin levels and dyslipidemia, followed by phenotype A, in our total study population. After classification of the study group into lean and obese groups, only few insulin and lipid-related traits showed marked differences between phenotypes. Further, we noted that obese women showed adverse metabolic but not androgenic traits compared to lean counterparts in the same phenotype. Metabolic syndrome frequency is increased in hyperandrogenic phenotypes with HDL-C and waist circumference being most predominant contributing factors in total, lean and obese groups. We demonstrate that in our study population there is greater occurrence of phenotype D of PCOS. Our study highlights the importance of clinicians concurrently employing Rotterdam criteria along with obesity status for ascertaining accurate PCOS status and formulating suitable therapeutic intervention.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Prevalence of components of metabolic syndrome in women with PCOS and controls.
Frequency of the components of metabolic syndrome in total (A), lean (B) and obese (C) women with PCOS and controls. BP = blood pressure; FBS = fasting blood sugar; HDL = high density lipoprotein; MS = metabolic syndrome; TG = triglycerides; WC = waist circumference.

Similar articles

Cited by

References

    1. Mukherjee S, Maitra A. Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome. The Indian journal of medical research. 2010;131:743–60. Epub 2010/06/24. - PubMed
    1. Sagvekar P, Dadachanji R, Patil K, Mukherjee S. Pathomechanisms of polycystic ovary syndrome: Multidimensional approaches. Front Biosci (Elite Ed). 2018;10:384–422. Epub 2018/01/03. 10.2741/e829 - DOI - PubMed
    1. Legro RS. Obesity and PCOS: implications for diagnosis and treatment. Seminars in reproductive medicine. 2012;30(6):496–506. Epub 2012/10/18. 10.1055/s-0032-1328878 - DOI - PMC - PubMed
    1. Amato MC, Verghi M, Galluzzo A, Giordano C. The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk. Hum Reprod. 2011;26(6):1486–94. Epub 2011/03/31. 10.1093/humrep/der088 - DOI - PubMed
    1. Shin KA, Kim YJ. Usefulness Of Surrogate Markers Of Body Fat Distribution For Predicting Metabolic Syndrome In Middle-Aged And Older Korean Populations. Diabetes Metab Syndr Obes. 2019;12:2251–9. Epub 2019/12/07. 10.2147/DMSO.S217628 - DOI - PMC - PubMed

Publication types

Substances